FDA clears NIDEK OCT system

Article

NIDEK’s optical coherence tomography system-the RS-3000 Advance-has received FDA clearance.

 

Fremont, CA-NIDEK’s optical coherence tomography system-the RS-3000 Advance-has received FDA clearance.

The imaging system, which incorporates a scanning laser ophthalmoscope, is designed for comprehensive evaluation of the retina and choroid. The product also provides detail of the retinal and chorodial microstructures to assist in clinical diagnosis.

“We are pleased to have this clearance, and confident the results reflect the quality of our diagnostic tools in imaging that assist doctors in diagnosing ocular diseases,” said Motoki Ozawa, president of NIDEK.

 

For more articles in this issue of Ophthalmology Times eReport, click here.

 

 

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

Related Videos
TENAYA, LUCERNE year 2 data reveals promising results for faricimab
How to diagnose geographic atrophy earlier
World Sight Day 2022: Eye care professionals share what global vision means to them
Samsara Vision update: Concerto trial recruiting patients with late-stage AMD
Understanding fluid dynamics in wet macular degeneration
YOSEMITE, RHINE treat-and-extend data show favorable results for faricimab for the treatment of DME
What are you most excited about in the field of retina? Tunde Peto, MD, PhD weighs in
Leveraging noninvasive ophthalmic imaging for patients with Alzheimer disease and analyzing UK Biobank data
EURETINA 2022: Leadership discusses what to expect, outlines Women in Retina program
DAVIO trial update: 12-month safety results indicate no serious adverse events, reduced treatment burden
© 2024 MJH Life Sciences

All rights reserved.